#USA #Probiotics #Chino #SEBiotic® #Specialty Enzymes&

New Clinical Trial Highlights SEBiotic®

In a groundbreaking clinical study, SEBiotic® (Bacillus coagulans LBSC) produced by Specialty Enzymes & Probiotics has been validated as a safe and effective treatment for drug-induced constipation associated with Functional Gastrointestinal Disorders (FGIDs). Published in Global Advances in Integrative Medicine and Health, this double-blind, randomized, control trial analyzed various clinical parameters to uncover the benefits of SEBiotic®.

Study Overview

Conducted with rigorous methodologies, the trial included a diverse group of participants battling drug-induced constipation symptoms. The excitement surrounding the study stemmed from its focus on not just the physical aspects of constipation, but also the emotional and overall quality of life impacts. Participants were monitored over a span of 35 days, marking significant changes in symptoms.

Impressive Results

The results are compelling—an astonishing 96.4% of the participants showed resolution of constipation after the intervention. Participants reported improved stool consistency and ease of expulsion as well as reduced occurrences of hard stool and increased defecation frequency. Beyond addressing physical symptoms, SEBiotic® supplementation significantly aided mental health, enhancing general health perceptions and minimizing bodily pain.

Quality of Life Boost

The benefits of SEBiotic® extend beyond digestive health; it played a notable role in improving physical and social functioning. This highlights its potential as a holistic solution for individuals whose daily lives are disrupted by the repercussions of drug-induced constipation.

Reshma Rathi, Vice President of Specialty Enzymes & Probiotics, emphasized the necessity of this research. “Chronic drug therapies can alter the gut microbiome, leading to symptoms that impact life quality. Our study demonstrates that SEBiotic® provides powerful support for those suffering from these conditions.”

Safety and Tolerability

One of the standout features of SEBiotic® is its favorable safety profile. The study confirmed that the product was well-tolerated, making it a reliable option for individuals with sensitive digestive systems. This aspect is crucial for patients often dealing with the side effects of medication, as finding non-invasive solutions is paramount in today's healthcare environment.

About Specialty Enzymes & Probiotics

Specialty Enzymes & Probiotics boasts over 45 years of experience in fermentation and is committed to delivering scientifically sound probiotic solutions. Their products undergo extensive testing in state-of-the-art, NSF GMP-certified facilities, ensuring the highest standards of quality and safety.

As a proud member of organizations such as the International Probiotic Association (IPA) and the Council for Responsible Nutrition (CRN), the company underlines its dedication to research-backed wellness solutions. Through trials and diverse publications in reputable journals, Specialty Enzymes & Probiotics has cultivated a reputation for promoting various aspects of health including joint support, immune function, and metabolism.

In summary, the findings surrounding SEBiotic® offer a promising pathway not only to relieve the discomforts of drug-induced constipation but also to enhance overall life quality. The meticulous research underscores the increasing value of probiotics in contemporary therapeutic practices, paving the way for more nuanced care for those affected by FGIDs.